# Suboxone tooth decay litigation

> Educational mass tort overview from DrugsMonitor.com. Not legal or medical advice.

**Canonical URL:** https://drugsmonitor.com/case/suboxone-tooth-decay-lawsuit
**Last updated:** 2026-06-11

## Key facts

- **Matter:** Suboxone Tooth Decay
- **Status:** Bellwether Prep
- **Scope:** United States — national overview
- **Drug safety page:** https://drugsmonitor.com/drug-info/suboxone-tooth-decay-lawsuit

## Overview

Litigation involving Suboxone sublingual film alleges that long-term placement of buprenorphine/naloxone film under the tongue exposes teeth and gums to acidic conditions, contributing to severe decay, extractions, and oral surgery in some patients.

### Clinical and product-use context

Suboxone film is designed to dissolve sublingually, delivering buprenorphine and naloxone as part of medication-assisted treatment. Plaintiffs’ complaints describe prolonged contact between dissolved medication and dental enamel, coupled with dry mouth or reduced saliva, as factors in rapid caries and tooth loss.

Defendants have disputed causation and labeling adequacy in court filings. As with any drug litigation, outcomes depend on individual medical histories, concurrent risk factors (tobacco use, prior dental disease, other medications), and evidentiary rulings.

### Litigation coordination

Federal cases have been centralized in the Northern District of Ohio. The MDL addresses common discovery into labeling, chemistry, marketing, and dental adverse-event reporting while leaving merits questions for individual or bellwether trials.

Bellwether scheduling gives parties a sense of how juries respond to causation and warning theories; settlements—if reached—often follow fact-specific negotiations rather than a single class-wide judgment.

---

*DrugsMonitor.com is not a law firm. For medical decisions consult a licensed clinician; for legal decisions consult a qualified attorney.*